Table 1 Inclusion and exclusion criteria for the review

Patient population

Patients with T2DM

Patients with T1D, Gestational diabetes, Healthy individuals, pre-diabetes

Interventions

Modelling studies assessing any pharmacological or non-pharmacological

intervention for the treatment of T2D

Study design

Cost-effectiveness analyses

Cost-utility analyses

Within trial Cost-effectiveness analyses,

Within trial Cost-utility analyses

Microsimulations, cohort models

Modelling application studies with a time horizon of ≥5 years

Modelling application studies with a time horizon of < 5 years

Country

Low-and-middle income countries

High income countries

Language

Published material in English

Published material not in English

Time frame

Evidence published since 2000 to 30 June 2020

Evidence published prior to 2000